Lisa C Zaba

7PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Tomoko Akaike, Manisha Thakuria, Ann W Silk

|Oct 18, 2023
Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.

Shira Tabachnick-Cherny, Thomas Pulliam, Haroldo J Rodriguez

|Oct 27, 2022
Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.

Mollie F Qian, Nicolas J Betancourt, Alain Pineda

|Sep 27, 2021
Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review.

Lucy Y Liu, Joyce M C Teng, Sheri L Spunt

|May 06, 2021
Rare and fatal complication of immune checkpoint inhibition: a case report of haemophagocytic lymphohistiocytosis with severe lichenoid dermatitis.

Sara Choi, Maggie Zhou, Eman Bahrani

|Feb 01, 2021
Telescope punch biopsy of normal-appearing skin to diagnose intravascular lymphoma.

M C G Winge, D J Iberri, R A Novoa

Pageof 2

Frequent Collaborators

3 joint publications

Paul Nghiem

2 joint publications

Song Youn Park

2 joint publications

Tomoko Akaike

2 joint publications

Daniel S Hippe